CagriSema is an investigational weight loss injection combining semaglutide 2.4 mg (a GLP-1 agonist, the drug in Wegovy) and cagrilintide 2.4 mg (an amylin analogue)
These infusions are not FDA approved for any given indications of treatment and are not considered a medical necessity
It delivers a concentrated dose of the antioxidant glutathione directly to your bloodstream, where it circulates throughout your body, supporting detoxification, cellular protection, and melanin regulation
Environmental factors, stress, and aging also contribute to its decline
At $200$500 per month, a medically supervised GLP-1 program at Peak Performance is often less than what people are already spending on medications, supplements, meal delivery kits, and gym memberships that arent producing results